MAXIGRATAN 150 Capsules
A Novel Direct Thrombin inhibitor Par Excellence
COMPOSITION: Dabigatran Etexilate Mesilate eq. to Dabigatran Etexilate 150mg
- Dabigatran etexilate mesylate is an outstanding anticoagulant, beneficial in the treatment of stroke and systemic embolism.
- Effective in the treatment of deep vein thrombosis, pulmonary embolism and non-valvular atrial fibrillation.
- Also used for the prevention of venous thromboembolic events in patients with recent elective hip or knee replacement surgery and atrial fibrillation.
- Benefits of DES (Dabigatran Etexilate Mesylate) includes a fast onset and offset of action, a relatively short half-life and limited drug-drug interaction.
- Demonstrates superiority over enoxaparin in treatment of venous embolism after orthopedic surgery.
- Clinical trials have proven that it is more efficacious than warfarin and does not require any coagulation monitoring.
- Also prevents and treats recurring blood clots in veins of legs and lungs.
INDICATIONS:
- Stroke
- Systemic embolism
- Deep vein thrombosis
- Pulmonary embolism
- Recurrent pulmonary embolism
- Non-valvular atrial fibrillation
Description
Dabigatran Etexilate
Drug class: Direct thrombin inhibitors
- Benefits of DES (Dabigatran Etexilate Mesylate) include a fast onset and offset of action, a relatively short half-life, and limited drug-drug interaction.
- Demonstrates superiority over enoxaparin in the treatment of venous embolism afteorthopedicic surgery.3
- Clinical trials have proven that it is more efficacious than warfarin and does not require any coagulation monitoring.
- Also prevents and treats recurring blood clots in veins of legs and lungs.
- Dabigatran etexilate mesylate is an outstanding anticoagulant, beneficial in the treatment of stroke and systemic embolism.
- Effective in the treatment of deep vein thrombosis, Pulmonary embolism, recurrent pulmonary embolism, and Non-valvular atrial fibrillation.’
- Also used for the prevention of venous thromboembolic events in patients with recent elective hip or knee replacement surgery and atrial fibrillation.
